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Abstract
Postpartum depression is recognized as the most common complication of childbearing;
however, its etiology remains fairly undetermined. Many different influences have been
hypothesized as to what may cause postpartum depression, including changes in levels of
various hormones (such as estrogen and progesterone), a decrease in serotonin, low levels
of vitamin D, social factors, and iron deficiency. The lack of strong evidence for one
specific cause makes it fairly clear that there are many factors that play a role in the
development of postpartum depression. Iron deficiency is one issue that is thought to
contribute to the development of postpartum depression due to iron’s role of oxygenating
the brain, as well as in the synthesis of some neurotransmitters and enzymes in the
nervous system. Therefore, iron deficiency can result in decreased oxygenation of the
brain tissue, which can result in depression symptoms, and it can also decrease the
number of certain neurotransmitters that are linked to depression.
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An Examination into the Relationship Between Iron Deficiency and Postpartum
Depression
Postpartum Depression
Postpartum depression (PPD) is the commonly-known name for a depressive
mood disorder that develops in women during pregnancy or following childbirth.
According to Delrosario, Chang, and Lee (2013), PPD is the most common complication
of childbearing as it occurs in about 15% of women in the postpartum period. Despite
PPD’s prevalence in postpartum women, its exact etiology remains unknown. Many
causes have been speculated and examined including changes in levels of various
hormones (such as estrogen and progesterone), a decrease in serotonin, low levels of
vitamin D, social factors, and iron deficiency (Delrosario et al., 2013).
Clinical Manifestations and Diagnosis
The 5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) is the official manual used to diagnose mental health issues. Oddly enough,
PPD does not exist in the DSM-5. The DSM-5 instead diagnoses PPD as a “major
depressive disorder (MDD) with peripartum onset” (American Psychiatric Association,
2013). The previous edition of the DSM, the DSM-IV, used the specifier of “postpartum
onset,” but the DSM-5 made the change in time specifier as a result of acknowledging
that half of major depressive episodes occur prior to delivery (Segre & Davis, 2013). The
use of the new peripartum onset specifier allows for the inclusion of major depressive
episodes that develop during pregnancy as well as during the four weeks following
delivery (Black & Grant, 2014). The diagnostic criteria for MDD provided by the DSM-5
are when a patient meets five or more symptom criteria from a list including depressed
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mood, loss of interest or pleasure, significant weight loss or weight gain, insomnia or
hypersomnia, psychomotor agitation, fatigue or loss of energy, feelings of worthlessness,
diminished ability to think or concentrate, and suicidal ideation (Black & Grant, 2014).
Despite the DSM-5 setting the time frame for MDD with a peripartum onset to be
during pregnancy and up to four weeks following delivery, in clinical practice, many
women are not diagnosed until six weeks to three months postpartum (Ellsworth-Bowers
& Corwin, 2012). In fact, the prevalence of PPD is about 7% in women during the first 3
months postpartum (Albacar, 2011). Although the DSM does not recognize PPD as its
own diagnosis, the use of the term “postpartum depression” is accepted throughout the
medical community, and in clinical practice, it is usual to have an onset past the
timeframe set by the DSM (Bozoky & Corwin, 2002).
It is also important to note that PPD is not the same as “baby blues” or postpartum
psychosis. “Baby blues,” which are essentially mood swings, are common in many
women in the early postpartum period. These mood swings are mild, often resolve within
ten days, and are never associated with suicidal ideation. Postpartum psychosis, on the
other hand, is to be taken extremely seriously. It rapidly occurs in the postpartum period
and is associated with delusions, confused thinking, and disorganized behavior. The
safety of the mother and baby is at risk in postpartum psychosis and hospitalization is
often required (Delrosario et al., 2013).
The Edinburgh Postnatal Depression Scale (EPDS) is a widely used, ten question
screening tool for PPD in pregnant or postpartum women (Cox, Holden, & Sagovsky,
1987). According to Bunevicius, Kusminskas, and Bunevicius (2009), the internal
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consistency of the EPDS is 0.83 by means of the Chronbach alpha coefficient, which
suggests adequate reliability.
Some examples of the types of questions asked are whether or not there has been
a change in the woman’s ability to find humor in her day-to-day life or whether or not she
looks forward with enjoyment to things. The questions assess for feelings of anxiousness,
unhappiness, insomnia, crying, and suicidal thoughts. The woman is to complete the
questionnaire by herself and check which of the four responses most closely relates to
how she has been feeling in the past seven days. The healthcare provider then grades the
responses with a score of 0, 1, 2, or 3. The scores attributed to each response are then
added together. A woman who has a total score of 10 or greater has possible depression
and women who score above 13 are likely to be suffering from a depressive illness. It is
of especially great importance to look at the woman’s answer to the last question. The
last question is a statement that says “the thought of harming myself has occurred to me”
and the patient is to respond with “Yes, quite often”, “sometimes”, “hardly ever”, and
“never”. Because this assesses for suicidal ideation, it is important to note the patient’s
response, regardless of the total score (Cox et al., 1987).
Treatment
Traditional first-line therapy for treating PPD is the use of medications and/or
psychotherapy. Psychotherapy--which may also be referred to as counseling-- is
considered an appealing option especially to women who are breastfeeding in order to
avoid any potential side effects on the baby. Selective serotonin reuptake inhibitors
(SSRIs) are first line medication choices for the treatment of PPD and are considered
effective in treating depressive symptoms. There is not a large body of evidence to
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contraindicate the use of antidepressants while breastfeeding; however, there are not
many long-term studies to examine the effects they could potentially have on the baby. A
common psychotherapy method used with PPD patients is cognitive behavior therapy.
This type of therapy encourages patients to change their thought patterns, as well as
improve their coping behaviors (Delrosario et al., 2013).
Iron Homeostasis
Due to iron’s role in oxygenation of the brain, as well as the function it plays in
the synthesis of some neurotransmitters and enzymes in the nervous system, a deficiency
in iron is hypothesized to have a responsibility in the development of PPD. It is therefore
important to discuss how iron is absorbed in the body, factors that prevent absorption,
and a more in depth look at the pathophysiology behind iron deficiency.
Iron is derived from the diet in two forms known as heme iron and non-heme iron.
Heme iron is derived from food of animal sources whereas non-heme iron comes from all
other sources. Molecularly, the difference between heme iron and non-heme is that heme
iron is tightly bound to a porphyrin ring structure (heme), whereas non-heme iron is not.
Heme iron is able to absorb into the bloodstream more easily than non-heme iron and is
not as affected by components of the diet like non-heme iron is. Phytate, polyphenols,
and tannic acid all inhibit the absorption of non-heme iron by binding to iron while it is in
the gastrointestinal tract, thus making it unable to be absorbed from the gastrointestinal
tract into the bloodstream. Citric acid, certain amino acids, and ascorbic acid are all
known to help promote the absorption of non-heme iron into the bloodstream. Citric acid
promotes non-heme iron absorption by chelating iron, while certain amino acids and
ascorbic acid convert ferric iron (the form the non-heme iron takes in the gastrointestinal
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tract) into a more soluble ferrous form. Due to the number of factors necessary to
promote non-heme iron absorption, as well as the factors that antagonize non-heme
absorption, the absorption of heme iron is considered more efficient than non-heme iron
(Beard & Han, 2009).
Once iron is released into the body’s circulation, it immediately binds with a βglobulin called apotransferrin. Together, these two molecules form transferrin. It is with
transferrin that iron can be transported in the plasma. Transferrin can also transport iron
to the bone marrow and bind to membrane receptors there in order to have the developing
RBCs take up the iron and use it for the synthesis of hemoglobin (Grossman, 2014a).
According to Grossman (2014a), women normally have about 2 grams of iron in
their bodies with the majority of this (about 80%) used to create hemoglobin. A small
amount of iron is found in the muscle (the myoglobin), the cytochromes, and some ironcontaining enzymes. The remaining iron is stored in the bone marrow, liver, spleen, and
some other organs (Grossman, 2014a).
Iron’s Role in Hemoglobin
Because iron is a component of heme, iron deficiency leads to decreased
hemoglobin synthesis. On the RBC, hemoglobin functions as the carrier of oxygen to the
body tissues. Because of this, when iron and hemoglobin are decreased, there is a
resulting impairment of oxygen delivery to the body cells. The hemoglobin molecule has
two pairs of alpha and beta polypeptide chains. Each of these chains consists of a globin
(which is a protein) and a heme unit. Each polypeptide chain can carry one molecule of
oxygen; so one hemoglobin molecule has the ability to carry four oxygen molecules. The
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rate at which hemoglobin is formed is dependent on the availability of iron in the body
readily available for that function (Grossman, 2014a).
As previously discussed, hemoglobin within the RBC is the primary transporter of
oxygen in the body as oxygen is relatively insoluble in the plasma. Within the lungs,
oxygen moves from the alveoli to the pulmonary capillary and then into the red blood
cells to bind to hemoglobin. Once oxygen binds to hemoglobin, the hemoglobin is known
as oxyhemoglobin. Once all four units of heme are bound to oxygen, the hemoglobin is
considered 100% saturated. When a blood cell enters a tissue capillary where the partial
pressure (PO2) is less than that of the arterial blood, the hemoglobin dissociates from the
O2. The O2 dissolves in the plasma and then moves into the tissues where it can be taken
up into body cells so that they can perform metabolic functions (Grossman, 2014b).
Iron’s Role in the Brain
Iron plays a role in the oxygenation of brain parenchyma (due to the function it
has in the synthesis of hemoglobin), but it also acts as an enzyme to synthesize
neurotransmitters, including serotonin, norepinephrine, and dopamine (Beard, 2001).
According to Hallgren and Sourander (1958), in the study of about 100 autopsied brains,
“the globus pallidus, the red nucleus, the substantia nigra and the putamen contain the
greatest amounts of iron”. Also, according to Kim and Wessling-Resnick (2014), iron is
especially concentrated in the basal ganglia, which is heavily influenced by dopamine
and GABA metabolism. Within these areas, the microglia and the oligodendrocytes are
the types of brain cells that contain ferritin (an iron storage protein), with the
predominant cell being the oligodendrocyte, which is responsible for the production of
myelin (Beard, 2003).
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Alterations in the functioning of oligodendrocytes are associated with
hypomyelination. Because of the high concentration of ferritin in oligodendrocytes, there
is an interest as to whether or not iron plays a role in the myelination of neurons. For that
reason, a large amount of research has been focused on the relationship between iron
deficiency and cognitive function in infants and young children through the study of rat
brains. It is thought that if iron deficiency had any impact on the under myelination of
neurons, it could cause developmental delays. While many studies provide evidence for
cognitive alterations in children developing potentially from iron deficiency, the number
of studies on adults is much more limited. Nonetheless, because myelination is mostly
completed in late adolescence and early adulthood, iron’s role in myelination is likely
less relevant for the purpose of discussing it in regards to women who are childbearing
and therefore at risk for PPD.
Iron deficiency’s effect on the brain. It has been demonstrated in studies that the
brain is sensitive to dietary iron intake (Beard, 2001). Iron is a cofactor for enzymes
involved in the synthesis of serotonin, norepinephrine, and dopamine (Bodnar, Cogswell,
& Mcdonald, 2005). Serotonin (5-HT) is suspected to play a role in the control of
appetite, sleep, mood states, hallucinations, pain perception, and vomiting and
underactivity of serotonin is believed to predispose to depression and anxiety disorders
(Wheeler & Grossman, 2014). Norepinephrine is proposed to function in learning and
memory and attribute value in reward systems (Wheeler & Grossman, 2014). Depending
on the area of the brain in which norepinephrine acts in, it can be either an inhibitory or
excitatory neurochemical, and its underactivity is thought to be involved in depression in
some people (Wheeler & Grossman, 2014). Dopamine is involved in mood, pleasure in
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reward systems, judgment, reasoning, and insight (Wheeler & Grossman, 2014).
Therefore, low levels of dopamine are associated with depression (Wheeler & Grossman,
2014).
Given that iron is a factor needed for the synthesis of certain neurotransmitters,
one would expect a nutritional iron deficiency to result in a lower brain concentration of
those neurotransmitters. Yet, in studies of rats, whole-brain concentrations of
norepinephrine and dopamine remained unchanged by iron deficiency (Beard, 2001).
However, according to Kim and Wessling-Resnick (2014), the activity of monoamine
oxidase is lower in humans with iron deficiency anemia. Monamines are “involved in the
regulation of mood, neuronal activity, and anxiety” (Kim & Wessling-Resnick, 2014, p.
1101), so if iron is involved in their activity and metabolism, iron deficiency may be
indirectly affecting mood.
In studies, the only neurotransmitter that is consistently affected by iron
deficiency is dopamine (Beard, 2001). In studies performed by Youdim (1990), it was
found that whole brain levels of dopamine were not affected in rats undergoing dietary
iron depletion. Dopamine receptor densities in these same rats were shown to be
significantly lowered in the striatum and nucleus accumbens. Because of this association,
it is believed that the biological and behavioral alterations that are observed when iron
status significantly drops are related to changes in the dopaminergic system.
Dopamine’s possible link to depression. Serotonin levels in the brain are most
traditionally associated with depression. Selective serotonin reuptake inhibitors (SSRIs)
are one of the most common antidepressants used in the treatment of depression and
PPD; yet, there are a number of people who take an SSRI and still maintain symptoms of
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anhedonia, loss of interest, fatigue, and a lack of energy (Fulmer, 2010). Because of these
untreated symptoms, researchers began to look more into the role of dopamine in
depression as it often is found in brain regions associated with pleasure, drive, reward,
and motivation (Fulmer, 2010). Because lack of pleasure and lack of motivation are two
of the core clinical manifestations of depression, dopamine is suspected to share a
responsibility in its development. Some clinical studies have shown certain dopamine
agonists, including bromocriptine, pramipexole, and ropinirole, exhibit antidepressant
properties (Nutt et al., 2007). Dopamine agonists’ antidepressant effects may further give
evidence of dopamine’s role in depression. To review, iron has a function in the synthesis
of dopamine and clinical testing shows that iron deficiency results in a significant
decrease in dopamine receptors in the brain. If alterations in the brain’s dopamine system
play a role in PPD, then iron deficiency could be the underlying factor.
Iron deficiency’s impact on cognitive function. Beard et al. (2005) collected
data on young South African women and the effect of iron deficiency anemia on maternal
emotions and cognition. The study was a double-blind randomized controlled
interventional trial of three groups of mothers. One group was iron-deficient and was
given a daily dose of 25 mg of vitamin C plus 10 μg of folic acid. The second group of
anemic mothers was given 125 mg of FeSO4, 25 mg of Vitamin C, and 10 μg of folic
acid. The control group was compromised of non-anemic mothers who received no
supplements. The Raven’s Colored Progressive Matrices test was administered to
subjects in order to assess nonverbal intelligence at 10 weeks and 9 months postpartum.
At the end of the trial, the anemic subjects who had been given iron supplements had a
25% improvement in scores on the Raven’s test and the nine-month scores were almost
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the same between the anemic iron supplemented subjects and the control group. The
anemic mothers who did not receive iron supplementation did not experience a
significant change in scores between 10 weeks and nine months and the scores were
lower than the other two groups. According to Beard et al., at 9 months postpartum,
women who were in the control group (non-anemic and did not receive supplementation)
had a mean score on the Raven’s test of 20.3 ± 1.0, and anemic mothers who received
supplementation had a mean score of 20.4 ± 1.0. Conversely, anemic mothers who did
not receive supplementation had a mean score of 16.7 ± 1.0 on the Raven’s test. The
results of this study show that iron deficiency may, in some scenarios, take part in the
poor cognitive functioning of adults; nevertheless, the exact mechanism is unclear.
Iron Deficiency
Iron deficiency is the most common nutrient deficiency in the world as it affects
greater than 50% of women of reproductive age (Beard et al., 2005). The term “iron
deficiency” is a term that encompasses iron deficiency anemia as well as tissue iron
deficiency. The latter, tissue iron deficiency, is commonly referred to as “depleted iron
stores” and iron deficiency anemia is a reflection of the later stages of this (Grossman,
2014a). Iron is a necessary component in oxidative metabolism and immunity as well as
the synthesis of monoamine neurotransmitters and the myelination of axons (Albacar et
al., 2011). It is also necessary for the functioning of many biochemical processes, such as
electron transfer reactions, gene regulation, the binding and transport of oxygen, and the
regulation of cell growth and differentiation (Beard, 2001). Probably iron’s most notable
role in the body is as a building block for hemoglobin, the oxygen-carrying molecule
vital for the function of the red blood cell (RBC). Because of its function in hemoglobin,
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when there is a deficiency of iron in the body, oxygen delivery to the body cells is
impaired.
Etiology of iron deficiency. In general, iron deficiency results from inadequate
intake of iron, an excessive turnover of RBCs, or an excessive loss of blood. The body is
efficient at recycling hemoglobin; when RBCs become too old (RBCs have a lifespan of
about 120 days), the spleen destroys them and releases iron into the circulation so it can
go to the bone marrow and be used in the creation of new RBCs (Grossman, 2014a).
Despite this recycling, there is a loss of about 1 mg of iron per day (Beard & Han, 2009).
This loss of iron is a normal occurrence, and it generally occurs through the
gastrointestinal tract (Beard & Han, 2009). Because of this regular loss of iron through
the feces, iron balance is maintained by absorbing 1-2 mg of iron daily (Grossman,
2014a). Blood loss that exceeds what the body normally excretes is what can result in
iron deficiency if there is not adequate absorption to compensate for the loss. Women
who are menstruating lose an additional 1.5-2.1 mg of iron per day, but this number
increases when an intrauterine device is in place (Beard & Han, 2009). Pregnant women
eliminate a source of this blood loss through ceasing to menstruate monthly; nevertheless,
due to increasing iron requirements, iron deficiency can result. Postpartum women are
also able to generally stop menstruating monthly if they choose to breastfeed, because
cessation of menstruation is frequently associated with the hormones released during
lactation. The cessation of menstruation associated with lactation is beneficial as it can be
a time to restore some depleted iron stores (Grossman, 2014a). If a woman makes the
decision not to breastfeed though, she is more likely to begin her menstrual cycle sooner
than a woman who does breastfeed (Grossman, 2014a). By restarting her menstrual cycle
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sooner, she will consequently lose more iron, which could potentially make the
replenishing of iron stores in the postpartum period more difficult (Grossman, 2014a).
With inadequate intake of iron through the diet, excessive turnover of RBCs (as in
hemolytic anemia where the excess hemoglobin in the blood may be excreted from the
body), or any of the conditions previously discussed, there will be a decrease in body iron
levels, and deficiency will result. With a decrease in body iron levels comes a decrease in
the amount of hemoglobin that can be synthesized. Subsequently, this results in smaller
red blood cells as they do not carry as much hemoglobin and cannot carry oxygen as well
to the body cells.
Development of iron deficiency in pregnancy. Iron deficiency is especially
common in pregnancy as it becomes difficult to balance increased iron requirements with
dietary intake (Consigli, 2016). Iron requirements during pregnancy increase due to the
growth of the fetus, placenta, and maternal blood volume (Consigli, 2016). Blood volume
increases in pregnancy in order to continue to supply oxygen to the mother’s body cells
as well as transfer oxygen to the developing fetus through the placenta. In order to
compensate for this increased oxygen demand, the mother’s iron requirement increases so
that the body can create more circulating RBCs. Increased demands for iron from the
fetus also contribute to the development of iron deficiency. The fetus begins to store iron
in the liver, especially during the third trimester of pregnancy in order to compensate for
low levels of iron found in breast milk for the first four months of life (Consigli, 2016).
Recommended intake of iron during pregnancy is 27 mg per day, and although the
rate of absorption increases during pregnancy, the most iron that can be reasonably
obtained from the average American diet is 15 to 18 mg per day (Consigli, 2016). Not
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meeting the recommended iron intake can result in low iron stores for the fetus and also
anemia for the mother well into the postpartum period (Consigli, 2016). For this reason,
all pregnant women should be taking a daily prenatal vitamin that includes iron and they
should also continue taking it well into the postpartum period.
Clinical manifestations. Patients with iron deficiency anemia may report feeling
tired, having difficulty concentrating, being less productive at work or home, or feeling
like they are lacking in energy (Beard, 2001). Assessment of the patient may reveal
palpitations, dyspnea, and tachycardia (Grossman, 2014a). In iron deficiency anemia,
tachycardia is a compensatory mechanism to increase oxygen transport to the body cells.
Because oxygen binding to hemoglobin is a quick process, when the body has an
increased heart rate, there can be more RBCs that reach the pulmonary capillaries and
have hemoglobin bind with oxygen for transport. Tachycardia also results in more RBCs
reaching the body tissues carrying oxygen. So in short, while the RBCs may be able to
carry less oxygen per cell, in order to compensate, there is a greater number of RBCs
reaching the tissues in the same amount of time. Iron deficiency can also result in
impaired thermoregulation, immune function, mental function, and physical performance
(Beard, 2001). These findings are all related to impaired oxygen transport and a lack of
hemoglobin. Findings will be dependent on how severe the anemia in the patient is. Other
physical symptoms may be brittle hair and nails, a smooth tongue, sores in the corners of
the mouth, or a spoon-shaped deformity of the fingernails known as koilonychias
(Grossman, 2014a).
Testing and diagnosis. Serum ferritin level is the most sensitive and specific test
used for the identification of depleted iron stores. According to the standards set by the
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World Health Organization (2011), a serum ferritin less than 15 μg/L generally indicates
depleted iron stores. Ferritin is a protein-iron complex that is used to store iron in the
liver but can also return it to the circulation easily (Grossman, 2014a). Serum ferritin is a
helpful indicator of iron status in the body because decreased levels generally indicate
decreased body stores (Grossman, 2014a).
A transferrin saturation level of less than 16% indicates an iron supply that is
insufficient to support normal erythropoiesis. Hemoglobin may be examined but this
value will only be depressed in iron deficiency anemia and not in tissue iron deficiency
(Camaschella, 2015). A hemoglobin test is performed in order to determine the
hemoglobin content of the blood. Normal values differ between men and women, with
men having a slightly higher range. Women ought to have a hemoglobin level within the
range of 12-15 g/dL (Grossman, 2014a). Hematocrit is also examined to determine the
presence of anemia. Hematocrit measures the percentage of RBCs in 100mL of plasma.
In men, hematocrit should be 40-50% and in women, it should be 37-47%. A low
hematocrit may indicate anemia (that there are not enough RBCs), so examining this with
other labs can determine anemia, as well as the cause (whether or not is related to iron
deficiency).
Iron deficiency will alter RBC size and shape as well as the number. Red blood
cell count will decrease and cells will be microcytic and hypochromic. RBC size and
shape can be determined through the laboratory tests for mean corpuscular hemoglobin
concentration (MCHC) and mean corpuscular volume (MCV). Mean corpuscular
hemoglobin concentration examines the concentration of hemoglobin in the RBC and
MCV examines the size of the RBC. Normal MCHC is 31-35 g/dL and lower than
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normal levels are seen with iron-deficiency anemia. A low MCHC results in
hypochromic RBCs meaning that they are paler than normal due to a decreased
hemoglobin level in the cell (hemoglobin is what gives RBCs the red color). Normal
MCV levels are 85-100 fL. Low levels of MCV are seen with iron-deficiency anemia as
it means that the RBCs are microcytic (smaller than normal) (Grossman, 2014a).
Testing in pregnant and postpartum women. Ferritin in the postpartum period
is expected to be low due to the decrease in iron stores in pregnancy and from blood loss
in delivery. Sometimes, however, this is not found to be the case. According to Muñoz,
Villar, and Garcia-Erce (2009), delivery produces an inflammatory response in women,
which can alter ferritin concentrations. The two acute inflammatory response proteins to
be noted in this case are C-reactive protein (CRP) and a1-acid-glycoprotein (AGP)
(World Health Organization, 2011). If these proteins are elevated, in order to account for
the resulting increase in ferritin, the cut-off for defining iron deficiency can be raised to a
ferritin concentration of less than 30 μg/L (World Health Organization, 2011).
According to Krafft, Huch, and Breymann (2003), even when iron stores are
actually depleted in the postpartum period, ferritin levels will be elevated as a result of
inflammation. Consequently, although ferritin is considered to be the most reliable
marker of iron status in the general population, it is less reliable in the postpartum period.
Treatment. In general, the goal for treatment for iron deficiency in both adults
and children is to treat the cause if there is chronic blood loss involved, increase intake of
iron through the diet, and administer supplemental iron. Because iron deficiency in
pregnancy is almost always due to inadequate intake of iron, the goal of treatment would
be to increase iron intake through the use of supplements.
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Rapid restoration of an iron-depleted state can be achieved by administering 125250 mg of ferrous sulfate orally daily (Beard & Han, 2009). In severe anemia of
pregnancy, doses of greater than 250 mg twice a day is common practice; however, this
further increases the common side effects of iron supplementation (Beard & Han, 2009).
Constipation and black stool are common side effects and may complicate patient
compliance (Beard & Han, 2009). Patients should be instructed that if they can tolerate it,
iron supplements should be taken between meals in order to enhance absorption (Beard &
Han, 2009). The negative of this advice is that iron supplements often cause
gastrointestinal discomfort on an empty stomach (Consigli, 2016). If possible, it may be
beneficial to begin supplementation in the second trimester once the nausea and vomiting
associated with the first trimester subside (Consigli, 2016). Using ferrous sulfate
supplements can replenish iron stores in a few months and once iron levels have reached
normal levels, the normal RDA dietary guidelines for iron intake should be maintained
(Beard & Han, 2009).
There could also be potential benefit in looking deeper into treatment options of
iron deficiency that are more efficient than traditional oral iron repletion. A study
performed by Becuzzi, Zimmerman, and Krafft (2014), found that intravenous iron
therapy was beneficial in replenishing depleted iron stores. Subjects in the experimental
group received a single infusion of 500 mg iron carboxymaltose 24-48 hours postpartum
and then took iron supplements daily for 6 weeks. Subjects in this group reported no
adverse effects to the intravenous iron. The control group subjects took iron supplements
for 6 weeks but received no intravenous iron. The average ferritin at 6 months was
significantly lower in the control group versus the experimental group; 32.9 μg/L versus
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57.7 μg/L respectively. This study was consistent with others that intravenous iron
replenishes iron stores more efficiently than oral iron but this particular study established
its long-term effect on iron levels. Intravenous iron therapy also provides the benefit of
less gastrointestinal side effects that may affect patient compliance in traditional oral iron
supplementation.
Patient education. Because phytate, polyphenols, and tannic acid (all found in
cereals and high fiber foods) can hinder iron absorption, patients should be educated to
avoid consuming foods with high levels of these along with iron supplementation (Beard
& Han, 2009). Caffeine can also hinder iron absorption, so patients should be told to
avoid taking iron supplements with drinks like coffee or soda. Patients should be
educated on what may help with iron absorption such as ascorbic acid and citric acid,
which can be found in citrus fruits (Beard & Han, 2009). For example, patients should be
encouraged to take iron supplements with something like a glass of orange juice. Patients
should also be encouraged to include good food sources of iron into their diet, such as
meat (specifically beef) as well as iron-fortified cereal and bread, lentils, beans, and
spinach. If, however, elevated cholesterol is a problem for the patient, he or she should be
taught to limit their consumption of red and organ meats and instead eat more fish and
poultry products. As vegetarian and vegan diets increase in popularity, it is also important
to address the dietary concerns associated with those diets. Vegan and vegetarian diets do
not include any meat products, which are good sources of iron. Patients who do not
consume meat products should be educated about other good sources of iron that follow
their dietary preferences. Patients should also be cautioned to limit their consumption of
cured meats (such as jerky) as sodium nitrate is often used to cure them (Grossman,
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2014a). Large amounts of nitrates can react with hemoglobin and cause it to have a lower
affinity for oxygen, meaning that less oxygen may combine with the hemoglobin
molecule for transport (Grossman, 2014a).
As previously stated, constipation and black stool are common side effects of iron
supplementation therapy. In order to alleviate some of the discomfort associated with
these side effects, the woman should be consuming adequate fluid and fiber in her diet
(Consigli, 2016). Pregnant women should be consuming at least 64-96 ounces of fluid
each day and avoiding caffeinated beverages due to their diuretic effect which can be
counterproductive when trying to increase fluid intake (Consigli, 2016).
Relationship Between Iron Deficiency and Postpartum Depression
As previously stated, it is extremely unlikely that iron deficiency is the single
cause of postpartum depression. Research regarding the subject is sometimes
inconclusive which further points to the deduction that iron deficiency does not solely
cause PPD. For example, Armony et al. (2012) published a study of 567 Chinese women
in a rural area of northern China and found no relationship between the maternal iron
status and postpartum depression. While this was a large study, it was completely
observational and it stopped screening subjects for PPD using the EPDS after six weeks
postpartum. As previously discussed, according to Ellsworth-Bowers and Corwin (2012),
in clinical practice, most women are not diagnosed until six weeks to three months
postpartum, so it could be argued that this study’s time frame was cut too short. Future
studies should take this consideration into account and evaluate blood levels for ferritin
and screen for PPD up to three months postpartum. This study also mainly was assessing
subjects’ hemoglobin as a way to screen for iron deficiency. The downfall of focusing on
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a subject’s hemoglobin status is that it is not the best indicator of iron status and it can be
affected by residential altitude above sea level and smoking (World Health Organization,
2011).
Despite the study concluding that there was no relationship between iron
deficiency and PPD, there are a number of other studies that have found a relationship.
While it is unknown why exactly there are different findings between studies, most
likely, it is another example of the complexity of PPD due to the many confounding
factors involved. Many factors take part in the development of postpartum depression,
and iron deficiency is likely a probable contributor. The lack of relationship found in the
study by Armony et al. does not mean that there is definitively a lack of a relationship
between iron deficiency and PPD. That specific study’s findings could boil down to a
number of confounding factors such as the rural location of the subjects, cultural
differences, differences in social support, a biological/genetic factor, or even an
unaccounted shortcoming of the study. One example of a likely confounding factor not
addressed by this study is that the majority of new Chinese mothers often are taken care
of and receive lots of positive support specifically from their mother or mother-in-law for
about the first 30 to 40 days postpartum (Cheng & Pickler, 2009). This time frame is
commonly referenced as “doing-the-month” and allows the new mother to follow cultural
practices to promote health and prevent disease while relatives take over many of the
house responsibilities and food preparation (Cheng & Pickler, 2009). Studies show that
Chinese mothers with limited family support often have a high level of depressive
symptoms, while those who receive the most support have lower incidences of depressive
symptoms (Cheng & Pickler, 2009). “Doing-the-month” is a cultural ritual for the
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Chinese and the level of support that family gives to women in the early postpartum
period is not often seen in western cultures. American culture often values independence
more and women often do not receive nearly as much support as Chinese women.
Stress is a predictor for PPD and because “doing-the-month” relieves many of the new
stresses for the new Chinese mother, it places Chinese mothers at lower risk for PPD
(Cheng & Pickler, 2009). Therefore, this could be a reason why the results of this study
were not similar to other past studies and the high levels of support could have been a
confounding factor.
Another example as to why this study may have a different outcome than others
that are similar is regarding cesarean sections. The article mentions that 60% of the births
in the study were by elective caesarean section, which according to the article, is common
practice in China (Armony et al., 2012). As mentioned previously, inflammation alters
serum ferritin levels. If a non-traumatic vaginal birth results in an elevated CRP that
alters ferritin readings, then a caesarean section, which is much more traumatic, is likely
going to result in a greater inflammatory reaction. The study by Armony et al. did not
assess for any markers of inflammation in the blood testing of subjects, which means the
ferritin levels of the subjects could not be accurately assessed nor could the researchers
throw out any subjects who had extremely high levels of inflammatory markers that
could skew their results and statistical analysis. Because ferritin is the most valuable
assessment of iron stores, this study’s basis of iron deficiency mostly on subject’s
hemoglobin values is probably not the most accurate.
A study of 729 Spanish women by Albacar et al. (2011) sought to find an
association of depleted iron stores and PPD. This study assessed multiple markers for

IRON DEFICIENCY AND POSTPARTUM DEPRESSION

24

iron depletion but focused on serum ferritin as this is a more sensitive and specific test for
iron deficiency and decreased levels (<30 μg per liter) indicates decreased body stores.
Blood tests were taken on subjects only once in the study at 48 hours following delivery.
This study also screened participants for PPD over a longer time frame than the Chinese
study by Armony et al. While it did not screen subjects for PPD during pregnancy, it
screened using the EPDS at 48 hours, eight weeks, and 32 weeks postpartum. It also used
a lower cutoff score on the EPDS than the Chinese study by Armony et al. For the study
of Spanish women by Albacar, the cutoff score was set for 9. According to Navarro et al.
(2007), lowering the cutoff score to 9 increases sensitivity for PPD to 100% and the
specificity to 89%. Women who scored above a 9 on the EPDS were then evaluated using
the criteria set by the DSM-IV for PPD to confirm a diagnosis. This study found an
association between PPD and low ferritin levels. In the group of women who developed
PPD, 38.5% met the criteria for depleted iron stores set by the World Health Organization
and of the non-PPD women, 23.3% had depleted iron stores (Albacar et al., 2011).
One of the reasons why iron deficiency was examined to be related to postpartum
depression in the first place is because of the overlap between some of the symptoms
seen between the two. These overlapping symptoms include diminished ability to think or
concentrate and fatigue or loss of energy. In studies, early postpartum fatigue was found
to be a predictor of postpartum depression (Bozoky & Corwin, 2002). This idea was
studied due to the fact that fatigue is a common symptom in all forms of depression
(Bozoky & Corwin, 2002). Since fatigue is a common symptom in many forms of
depression, and it is considered a predictor of postpartum depression, it raises interest in
the relationship between fatigue and PPD. Because the symptom of fatigue seen with iron
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deficiency is directly related to a deficiency in hemoglobin and thus a deficiency in
oxygen transport, it raises the question as to whether or not a potential lack of oxygen
plays a significant role in postpartum depression.
Iron’s function in hemoglobin is not the only role of significance, though.
Because it also has a job in the synthesis of neurotransmitters, clinical evidence shows
that iron status has a part in affecting cognitive function (Beard et al., 2005), seemingly
independent of its role with hemoglobin. The potential link between iron levels and the
brain’s dopamine system was discussed earlier, and because dopamine is thought to play
a part in feelings of pleasure, drive, reward, and motivation (Fulmer, 2010) it is thought
that lower levels of dopamine receptors could be hampering these feelings and playing a
position in the development of PPD, thus linking iron levels to PPD.
Implications
If there is a connection between maternal iron status and PPD, even if it is just
one of the number of contributing factors, then health professionals need to be better
educating pregnant patients about iron deficiency. Specifically, this education can
include: how patients can make better diet choices; how to take iron supplements so that
they will be best absorbed; and actions they can take to decrease the side effects of
supplementation (so that compliance will be increased). Taking the extra time to educate
patients on the topic is a small price to pay when compared to the social and economic
consequences of PPD. Treatment for iron deficiency should be re-evaluated if the patient
does not respond or act on patient education. As previously discussed, intravenous iron
has shown promising results in replenishing iron stores. Also, because it is administered
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as a single infusion, patient compliance is not an issue with this treatment option like it is
with oral supplementation.
Conclusions
American culture generally sees the birth of a new child as a happy time in a
mother’s life, so in the past, when a woman struggled with PPD, it was almost never
discussed. Postpartum depression can cause a new mother to face a lack of energy,
depressed mood, and have negative thoughts, which is contrary to what culture somewhat
expects new mothers to experience in the postpartum period. When a mother has these
feelings, she may feel afraid to discuss them as she may feel as if she is wrong to feel the
way she does. She may not be aware that those feelings are a part of a mental disorder
and that she is not alone in experiencing it. Thus, it is vital for healthcare providers to
build a trusting relationship with their patients so that mothers will feel safe enough to
express their thoughts and feelings and can receive the help they need. Postpartum
depression has the potential to negatively affect the maternal-child relationship and
potentially even the child’s development (Delrosario et al., 2013). The social impact that
this disorder can have should drive medicine to investigate this disorder more deeply so
that more links can be made to PPD and it can be better prevented. Clinical evidence
appears to point to a relationship between iron deficiency and PPD, but there are many
confounding variables to take into account. Regardless of the sometimes blurry
connection between iron status and PPD, all pregnant patients should be encouraged to
consume adequate iron through diet and daily prenatal vitamins throughout pregnancy as
well as into the postpartum period in order to prevent iron deficiency or lessen its
potential severity and consequently decrease the risk of developing PPD in the process.
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The importance of the relationship between PPD and iron deficiency ought to alter the
way PPD is viewed. Instead of seeing it as a disorder that is treatable once diagnosed,
thinking can be shifted and, ideally, it can instead be seen as having potentially
preventable factors. With proper patient education and treatment of preventable factors,
the prevalence of PPD could be reduced, having a monumental impact on women’s
health.
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